Will AI-based tools embedded into risk based-monitoring prompt an Agile project management moment for clinical research? Sidharth Ananthanarayan explains why AI-based tools are not the answer but part of it.
- Why Clinical Trial Sites Are Drowning In Tech Chaos
- The Risks And Unresolved Rules Of Real-Time Clinical Trials
- What Real-Time Clinical Trials Demand From Your Tech Stack
- The FDA's RTCT Push: What It Is; Why It Matters
- Pharma's Digital Transformation: Where It's Really At
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Why An eTMF? It's Time For A Specialized Digital Solution
Clinical trials generate reams of documents. Use an electronic trial master file to streamline much of the work of document management, logging, and compliance.
-
Cytokine Release Syndrome Monitoring
Here we introduce an innovative risk-monitoring solution aimed at mitigating Cytokine Release Syndrome (CRS), a critical complication in immunotherapy that often leads to prolonged hospitalization.
-
Empowering Freenome: Large-Scale Data Quality And Compliance
Delve into five ways this biotech company was able to successfully deliver data quality and compliance for large-scale trials while developing next-generation blood tests for early cancer detection.
-
QT Monitoring Impacts More Than Just Cardiac Health
Achieve earlier detection of potential adverse cardiac events and refine patient selection for future trial phases by implementing advanced QT monitoring tools.
-
How AI And ML Can Transform Clinical Trial Conduct
There’s no doubt that 2023 will be remembered as the year that artificial intelligence and machine learning became mainstream. Gain an overview of the uses of AI and ML in clinical conduct.
-
Maximizing Site Performance: The Hidden Benefits Of Unified eConsent And EDC
Disconnected systems for eConsent and EDC create inefficiencies that burden clinical trial teams, but modern integrated platform solutions are streamlining operations.
-
Don't Just Swap The Engine. Redesign The Factory.
Discover how AI-native technology is accelerating study startup, streamlining operations, and helping sponsors and CROs deliver therapies to patients faster.
-
Why Oncology Drug Development Lags In Digital Biomarkers
Despite technological advances, oncology drug development research has lagged in adopting wearable digital biomarkers. Explore this space's unique challenges and the benefits of wearable technology.
-
Paper vs. eCOA: Hard Calculations For Easy Decisions
Sticker prices often guide purchases, but there's a broader perspective that encompasses total cost. Use this calculator to compare prices of paper COAs or eCOAs, including ePROs, eDiaries, and eClinROs.
-
Modern Post-Market Trials Driven By RWD – Is Your EDC Ready?
Explore the transformative role of real-world data (RWD) and advanced Electronic Data Capture (EDC) systems in post-market research, marking a departure from traditional Phase IV trials.
RECENT NEWSLETTERS
- 06.18.26 -- AI, eSource, And Site Tech: What's Actually Working In Trials
- 06.11.26 -- AI Governance, Site Tech Risk, And Trial Efficiency Gains
- 06.06.26 -- Best Of May: AI Risk, CRO Strategy, And Trial Cost Control
- 06.04.26 -- Why Clinical Execution — Not Tech — Is Trials' Biggest Risk
- 05.28.26 -- FDA's Elsa AI Shift, RTCT Rules, And RWE That Works